English
FranįaisObbligazione Royalty Pharma 2.2% ( US78081BAD55 ) in USD
| Emittente | Royalty Pharma | ||||
| Prezzo di mercato |  100 USD ▲ |
||||
| Paese |  Stati Uniti
|
||||
| Codice isin |
 US78081BAD55 ( in USD )
|
||||
| Tasso d'interesse | 2.2% per anno ( pagato 2 volte l'anno) | ||||
| Scadenza | 02/09/2030 | ||||
| Importo minimo | 2 000 USD | ||||
| Importo totale | 1 000 000 000 USD | ||||
| Cusip | 78081BAD5 | ||||
| Standard & Poor's ( S&P ) rating | BBB ( Lower medium grade - Investment-grade ) | ||||
| Moody's rating | Baa2 ( Lower medium grade - Investment-grade ) | ||||
| Coupon successivo | 02/03/2027 ( In 129 giorni ) | ||||
| Descrizione dettagliata |
Royalty Pharma č una societā di investimento biofarmaceutico che acquista diritti di royalty su farmaci giā approvati. The Obbligazione issued by Royalty Pharma ( United States ) , in USD, with the ISIN code US78081BAD55, pays a coupon of 2.2% per year. The coupons are paid 2 times per year and the Obbligazione maturity is 09/02/2030 The Obbligazione issued by Royalty Pharma ( United States ) , in USD, with the ISIN code US78081BAD55, was rated Baa2 ( Lower medium grade - Investment-grade ) by Moody's credit rating agency. The Obbligazione issued by Royalty Pharma ( United States ) , in USD, with the ISIN code US78081BAD55, was rated BBB ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||
| |||||